New CCDS guidelines aim to standardize diagnosis in senior dogs

An international working group has published what appears to be the first consensus-based diagnostic guidelines for canine cognitive dysfunction syndrome, or CCDS, giving veterinarians a more standardized way to define, stage, diagnose, and monitor age-related cognitive decline in dogs. The guidelines, published in the Journal of the American Veterinary Medical Association and led by North Carolina State University neurologist Natasha Olby, define CCDS as a chronic, progressive, age-associated neurodegenerative syndrome affecting the DISHAA behavioral domains: disorientation, social interaction, sleep disruption, house soiling, learning and memory, activity changes, and anxiety. The group proposes three severity stages and two diagnostic levels, with Level 1 centered on progressive history, exclusion of comorbidities, and clinical workup, and Level 2 adding MRI evidence of cortical atrophy with normal CSF cell counts. (elib.tiho-hannover.de)

Why it matters: For primary care teams, the biggest shift is practical: the paper moves CCDS closer to a structured diagnosis instead of a vague rule-out for “normal aging.” The working group recommends annual behavioral screening starting at age 7, with routine screening every 6 to 12 months to establish a baseline and catch change earlier. It also endorses repeated use of caregiver questionnaires, especially DISHAA in practice settings, while noting that CADES and CCDR may also be useful. That could help clinics separate cognitive decline from pain, sensory loss, endocrine disease, neurologic disease, or other common geriatric comorbidities that can look similar in the exam room. (elib.tiho-hannover.de)

What to watch: Expect follow-on work around blood biomarkers, cognitive testing batteries, and future revisions as better population data and longitudinal monitoring tools become available. (elib.tiho-hannover.de)